Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Antiangiogenic Agents in Advanced NSCLC
Antiangiogenic Agents in Advanced NSCLC
by ellena-manuel
Jared Weiss, MD . Assistant . Professor of Medici...
EGFR-Mutated Advanced NSCLC
EGFR-Mutated Advanced NSCLC
by sherrill-nordquist
The Coming Paradigm Shift. Faculty. Suresh S. Ram...
Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)
Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)
by stefany-barnette
Renato G. Martins, MD, MPH. Medical Director, Tho...
Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC
Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC
by southan
Beth . Eaby. -Sandy, MSN, CRNP, OCN. ®. Nurse Pra...
Consensus or Controversy?  
Consensus or Controversy?  
by okelly
Addressing Practical Clinical Questions Across the...
Beth Sandy, MSN, CRNP Nurse Practitioner
Beth Sandy, MSN, CRNP Nurse Practitioner
by PriceOfFreedom
Abramson Cancer Center . University of Pennsylvani...
Please note, these are the
Please note, these are the
by disclaimercanon
actual. . video-recorded proceedings from the . l...
The Role of Antiangiogenic Agents
The Role of Antiangiogenic Agents
by luanne-stotts
The Role of Antiangiogenic Agents in the Changin...
Thierry
Thierry
by cheryl-pisano
Le Chevalier, . MD. The Role of Translational Res...
James Yang,
James Yang,
by pasty-toler
MD. The Evolving Treatment Landscape in NSCLC: Co...
Michael
Michael
by luanne-stotts
Brada. . Torino. . 6 March 2015. Perspectives...
Using Non-targeted Therapies in Targeted Lung Cancer Popula
Using Non-targeted Therapies in Targeted Lung Cancer Popula
by ellena-manuel
Nathan Pennell, M.D., Ph.D.. September 6, 2014. O...
Please note, these are the actual video-recorded
Please note, these are the actual video-recorded
by chaptoe
proceedings from the live CME event and may includ...
Treatment in Advanced Non-Small Cell Lung Cancer
Treatment in Advanced Non-Small Cell Lung Cancer
by oconnor
. 5. th. most commonly diagnosed cancer in Austra...
iJOURNAL CLUB: Optimizing Therapy for Patients with Metastatic Squamous Cell Carcinoma of the Lung
iJOURNAL CLUB: Optimizing Therapy for Patients with Metastatic Squamous Cell Carcinoma of the Lung
by berey
Interview with Shirish M . Gadgeel. , MD . January...
Detection of Mutations in EGFR in Circulating Lung-Cancer C
Detection of Mutations in EGFR in Circulating Lung-Cancer C
by sherrill-nordquist
Colin Reisterer and Nick Swenson. S. . Maheswaran...
Integration of Immunotherapy Across
Integration of Immunotherapy Across
by karlyn-bohler
the Spectrum of Lung Cancer. Karen Kelly, MD. Pro...
Integration of Immunotherapy Across
Integration of Immunotherapy Across
by pamella-moone
the Spectrum of Lung Cancer. Karen Kelly, MD. Pro...
Optimal treatment for elderly patients with NSCLC
Optimal treatment for elderly patients with NSCLC
by cheryl-pisano
Giorgio V. Scagliotti. University. of . Torino,....
NA_00092076/ J1414, Protocol Version 4.8 Dated 13November2018
NA_00092076/ J1414, Protocol Version 4.8 Dated 13November2018
by singh
1 Study Title: Neoadjuvant Nivolumab, or Nivoluma...
The Winship Cancer Institute of Emory University
The Winship Cancer Institute of Emory University
by jalin
July 22, 2023. Adjuvant immunotherapy for resectab...
INTRODUCTION RESULTS
INTRODUCTION RESULTS
by arjun383
Mason Alford, MSc. a. , . Candace J. Grisham, MS. ...
Lung Tumors
Lung Tumors
by lorenzo155
4/1/24. Michael Forte, MD. Outline . Lung Cancer ...
Targeting KRAS G12C  in Solid Tumors
Targeting KRAS G12C  in Solid Tumors
by morton
: . A . New Anticancer Approach  . Marwan Fakih, ...
Terapia
Terapia
by min-jolicoeur
targeted. : . limiti e successi nelle metastasi ...
Targeting KRAS and down streaming
Targeting KRAS and down streaming
by alexa-scheidler
pathways. Federico Cappuzzo. Istituto Toscano Tum...
Second line
Second line
by alida-meadow
treatments. in WT . pts. : . which. . opportuni...
Italian cohort of
Italian cohort of
by test
nivolumab. Expanded Access . Programme. (EAP): ...
Minesh Mehta, Northwestern University
Minesh Mehta, Northwestern University
by mitsue-stanley
Chicago, IL. Radiation for Prevention and Treatme...
Lung cancer Treatment
Lung cancer Treatment
by attentionallianz
Consequences of the Lack of Patients of color &...
Please note, these are the
Please note, these are the
by vizettan
actual. . video-recorded proceedings from the . l...
Instructions for Use of These Slides
Instructions for Use of These Slides
by carla
The purpose of these slides is to serve as a resou...
Small cell lung cancer (SCLC):
Small cell lung cancer (SCLC):
by faith
an . introduction. Last updated: . July . 2020. In...
Mechanisms of ALK Resistance & Implications for Treatment
Mechanisms of ALK Resistance & Implications for Treatment
by evans
Robert C. Doebele, MD, PhD. Associate Professor, ....
ALK in lung cancer: Past, present, and future
ALK in lung cancer: Past, present, and future
by belinda
Gene Mutations in Lung . Adenocarcinomas. 17 years...
New developments in oncological treatment for Stage 3 NSCLC
New developments in oncological treatment for Stage 3 NSCLC
by summer
Lung SSG 22. nd. May 2018. Gareth Ayre. Rationale...
Second line treatments in WT
Second line treatments in WT
by deena
pts. : . which. . opportunities. with . biologic...
The formula Blueprint Medicines (BPMC)
The formula Blueprint Medicines (BPMC)
by erica
The sum of Blueprint’s pieces exceeds current va...
Phase II studies of Nivolumab
Phase II studies of Nivolumab
by brianna
in patients with Advanced . Squamous. (SQ) or Non...